Mesalamine SR Pellets Manufacturer in India

Mesalamine SR Pellets – Pharmaceutical-Grade Sustained-Release Pellets

Mesalamine SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Mesalamine (5-Aminosalicylic Acid / 5-ASA) as the active ingredient. Mesalamine has CAS Number 89-57-6, molecular formula C₇H₇NO₃, and molecular weight 153.14 g/mol. The active ingredient is incorporated into a pellet system designed to provide a controlled release profile over an extended period.

Sustained-release Mesalamine pellets can be developed using suitable matrix or polymer-coating technologies to regulate the release of the active ingredient. The multiparticulate format provides flexibility for capsule-filling and other oral dosage-form applications. Published formulation research has demonstrated highly loaded Mesalamine pellets with polymer-controlled extended release, showing that pellet coating and formulation composition have a major influence on release characteristics.

Commercially available Mesalamine SR pellet products are reported in different active loadings. A pharmaceutical pellet manufacturer lists 70%, 80% and 90% w/w Mesalamine SR Pellets, while another manufacturer reports 75% and 90%. These are commercial reference strengths and should not automatically be treated as SDP-approved strengths unless confirmed against the current SDP product specification.

Mesalamine SR Pellets can be used as a formulation intermediate for sustained-release oral multiparticulate products. The final release profile, active loading, pellet size, coating level and other critical quality attributes should be controlled according to the approved product specification.

Key Features

• Pharmaceutical-grade Mesalamine SR Pellets
• Active ingredient: Mesalamine / 5-Aminosalicylic Acid / 5-ASA
• CAS Number: 89-57-6
• Sustained-release multiparticulate format
• Suitable for controlled-release formulation development
• Suitable for capsule-filling applications
• Product-specific active loading
• Controlled pellet coating or matrix characteristics
• Formulation flexibility for oral dosage forms
• Suitable for bulk pharmaceutical manufacturing requirements

Applications

Sustained-Release Oral Formulations
Mesalamine SR Pellets are designed for formulations requiring an extended release profile of Mesalamine.

Capsule Filling
The multiparticulate format is suitable for incorporation into capsule dosage forms, subject to the final formulation design.

Multiparticulate Formulation Development
Individual pellets can be engineered with controlled release characteristics to achieve the required dissolution profile.

Pharmaceutical Manufacturing
Mesalamine SR Pellets can be supplied as a formulation intermediate for pharmaceutical manufacturers developing sustained-release oral products.

Bulk Supply
The product can be supplied for bulk formulation requirements with active loading and quality parameters defined according to the applicable specification.

Why Mesalamine SR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Sustained-Release Format – Developed for controlled and extended release of Mesalamine.
• Product-Specific Active Loading – Mesalamine concentration is defined according to the applicable product specification.
• Multiparticulate Format – Suitable for capsule-filling and other oral multiparticulate applications.
• Controlled Pellet Characteristics – Pellet size, coating/matrix characteristics and release performance can be controlled according to formulation requirements.
• Formulation Flexibility – Suitable for different sustained-release formulation development requirements.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical manufacturing and bulk formulation requirements.
• Mesalamine Pellet Supplier Support – Product information and supply parameters can be aligned with customer requirements.

Get Bulk Quote via WhatsApp